{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:02:28Z","timestamp":1787882548914,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T00:00:00Z","timestamp":1294617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/aps.2010.187","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T09:21:31Z","timestamp":1294651291000},"page":"217-222","source":"Crossref","is-referenced-by-count":41,"title":["Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats"],"prefix":"10.1038","volume":"32","author":[{"given":"Xue-qin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-dan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,10]]},"reference":[{"key":"BFaps2010187_CR1","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","volume":"54","author":"NW Morrell","year":"2009","unstructured":"Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S20\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"BFaps2010187_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1055\/s-0029-1233307","volume":"30","author":"RM Tuder","year":"2009","unstructured":"Tuder RM . Pathology of pulmonary arterial hypertension. Semin Respir Crit Care Med 2009; 30: 376\u201385.","journal-title":"Semin Respir Crit Care Med"},{"key":"BFaps2010187_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/07853890600622143","volume":"38","author":"A Raiesdana","year":"2006","unstructured":"Raiesdana A, Loscalzo J . Pulmonary arterial hypertension. Ann Med 2006; 38: 95\u2013110.","journal-title":"Ann Med"},{"key":"BFaps2010187_CR4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2174\/138161209787846757","volume":"15","author":"JA Eble","year":"2009","unstructured":"Eble JA, Niland S . The extracellular matrix of blood vessels. Curr Pharm Des 2009; 15: 1385\u2013400.","journal-title":"Curr Pharm Des"},{"key":"BFaps2010187_CR5","doi-asserted-by":"publisher","first-page":"H1451","DOI":"10.1152\/ajpheart.00127.2008","volume":"295","author":"SR Lammers","year":"2008","unstructured":"Lammers SR, Kao PH, Qi HJ, Hunter K, Lanning C, Albietz J, et al. Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves. Am J Physiol Heart Circ Physiol 2008; 295: H1451\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFaps2010187_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1183\/09031936.01.00084601","volume":"18","author":"E Frisdal","year":"2001","unstructured":"Frisdal E, Gest V, Vieillard-Baron A, Levame M, Lepetit H, Eddahibi S, et al. Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J 2001; 18: 838\u201345.","journal-title":"Eur Respir J"},{"key":"BFaps2010187_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1203\/PDR.0b013e31815b690d","volume":"63","author":"N Ambalavanan","year":"2008","unstructured":"Ambalavanan N, Nicola T, Li P, Bulger A, Murphy-Ullrich J, Oparil S, et al. Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr Res 2008; 63: 26\u201332.","journal-title":"Pediatr Res"},{"key":"BFaps2010187_CR8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.33549\/physiolres.930238","volume":"51","author":"J Novotn\u00e1","year":"2002","unstructured":"Novotn\u00e1 J, Herget J . Possible role of matrix metalloproteinases in reconstruction of peripheral pulmonary arteries induced by hypoxia. Physiol Res 2002; 51: 323\u201334.","journal-title":"Physiol Res"},{"key":"BFaps2010187_CR9","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1183\/09031936.05.00072504","volume":"25","author":"H Lepetit","year":"2005","unstructured":"Lepetit H, Eddahibi S, Fadel E, Frisdal E, Munaut C, Noel A, et al. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J 2005; 25: 834\u201342.","journal-title":"Eur Respir J"},{"key":"BFaps2010187_CR10","doi-asserted-by":"publisher","first-page":"L789","DOI":"10.1152\/ajplung.90306.2008","volume":"295","author":"M Aytekin","year":"2008","unstructured":"Aytekin M, Comhair SA, de la Motte C, Bandyopadhyay SK, Farver CF, Hascall VC, et al. High levels of hyaluronan in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2008; 295: L789\u201399.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFaps2010187_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.coph.2009.02.005","volume":"9","author":"MR MacLean","year":"2009","unstructured":"MacLean MR, Dempsie Y . Serotonin and pulmonary hypertension \u2014 from bench to bedside? Curr Opin Pharmacol 2009; 9: 281\u20136.","journal-title":"Curr Opin Pharmacol"},{"key":"BFaps2010187_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-1-60761-500-2_20","volume":"661","author":"MR MacLean","year":"2010","unstructured":"MacLean MR, Dempsie Y . The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med Biol 2010; 661: 309\u201322.","journal-title":"Adv Exp Med Biol"},{"key":"BFaps2010187_CR13","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/01.ATV.20.10.2233","volume":"20","author":"A K\u00e9reveur","year":"2000","unstructured":"K\u00e9reveur A, Callebert J, Humbert M, Herv\u00e9 P, Simonneau G, Launay JM, et al. High plasma serotonin levels in primary pulmonary hypertension: effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol 2000; 20: 2233\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFaps2010187_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1745-7254.2005.00071.x","volume":"26","author":"D Song","year":"2005","unstructured":"Song D, Wang HL, Wang S, Zhang XH . 5-Hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells are extracellular signal-regulated kinase pathway dependent. Acta Pharmacol Sin 2005; 26: 563\u20137.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2010187_CR15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1440-1681.2006.04485.x","volume":"33","author":"XQ Li","year":"2006","unstructured":"Li XQ, Hong Y, Wang Y, Zhang XH, Wang HL . Sertraline protects against monocrotaline-induced pulmonary hypertension in rats. Clin Exp Pharmacol Physiol 2006; 33: 1047\u201351.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFaps2010187_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1440-1681.2009.05168.x","volume":"36","author":"FG Zhai","year":"2009","unstructured":"Zhai FG, Zhang XH, Wang HL . Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats. Clin Exp Pharmacol Physiol 2009; 36: 850\u20136.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFaps2010187_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1183\/09031936.03.00038903","volume":"22","author":"P Dorfm\u00fcller","year":"2003","unstructured":"Dorfm\u00fcller P, Perros F, Balabanian K, Humber M . Inflammation in pulmonary arterial hypertension. Eur Respir J 2003; 22: 358\u201363.","journal-title":"Eur Respir J"},{"key":"BFaps2010187_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/CRD.0b013e3181cd612f","volume":"18","author":"R Mathew","year":"2010","unstructured":"Mathew R . Inflammation and pulmonary hypertension. Cardiol Rev 2010; 18: 67\u201372.","journal-title":"Cardiol Rev"},{"key":"BFaps2010187_CR19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1378\/chest.08-2420","volume":"136","author":"A Chaouat","year":"2009","unstructured":"Chaouat A, Savale L, Chouaid C, Tu L, Sztrymf B, Canuet M, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009; 136: 678\u201387.","journal-title":"Chest"},{"key":"BFaps2010187_CR20","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","volume":"54","author":"PM Hassoun","year":"2009","unstructured":"Hassoun PM, Mouthon L, Barber\u00e0 JA, Eddahibi S, Flores SC, Grimminger F, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009; 54: S10\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"BFaps2010187_CR21","first-page":"963","volume":"5","author":"HL Wang","year":"2004","unstructured":"Wang HL . The serotonin receptor and transporter are potential therapeutic targets for pulmonary hypertension. Curr Opin Investig Drugs 2004; 5: 963\u20136.","journal-title":"Curr Opin Investig Drugs"},{"key":"BFaps2010187_CR22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.pnpbp.2006.01.029","volume":"30","author":"CW Tsao","year":"2006","unstructured":"Tsao CW, Lin YS, Chen CC, Bai CH, Wu SR . Cytokines and serotonin transporter in patients with major depression. Prog Neruopsychopharmacol Bio Psychiatry 2006; 30: 899\u2013905.","journal-title":"Prog Neruopsychopharmacol Bio Psychiatry"},{"key":"BFaps2010187_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2003.07.016","volume":"49","author":"OM Abdel-Salam","year":"2004","unstructured":"Abdel-Salam OM, Baiuomy AR, Arbid MS . Studies on the anti-inflammatory effect of fluoxetine in rat. Pharmacol Res 2004; 49: 119\u201331.","journal-title":"Pharmacol Res"},{"key":"BFaps2010187_CR24","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.104.524926","volume":"111","author":"C Guignabert","year":"2005","unstructured":"Guignabert C, Raffestin B, Benferhat R, Raoul W, Zadigue P, Rideau D, et al. Serotonin transporter inhibition prevents and reversers monocrotaline-induced pulmonary hypertension in rats. Circulation 2005; 111: 2812\u20139.","journal-title":"Circulation"},{"key":"BFaps2010187_CR25","first-page":"255","volume":"40","author":"XM Wang","year":"2009","unstructured":"Wang XM, Zhou TF, Liu B, Wei L, Shi K, Zhao SS, et al. Changes of MMP-2,9 and TIMP-1 expressions in rats with pulmonary arterial hypertension after captopril and losartan interventions. Sichuan Da Xue Xue Bao Yi Xue Ban 2009; 40: 255\u20139.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"BFaps2010187_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1165\/ajrcmb.18.4.2536","volume":"18","author":"CA Tozzi","year":"1998","unstructured":"Tozzi CA, Thakker-Varia S, Yu SY, Bannett RF, Peng BW, Poiani GJ, et al. Mast cell collagenase correlateds with regression of pulmonary vascular remodeling in the rat. Am J Respir Cell Mol Biol 1998; 18: 497\u2013510.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFaps2010187_CR27","first-page":"131","volume":"36","author":"H Emonard","year":"1990","unstructured":"Emonard H, Grimoud JA . Matrix metalloproteinases. Cell Mol Biol 1990; 36: 131\u201353.","journal-title":"Cell Mol Biol"},{"key":"BFaps2010187_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1183\/09031936.00126907","volume":"32","author":"A Fabre","year":"2008","unstructured":"Fabre A, Marchal-Somm\u00e9 J, Marchand-Adam S, Quesnel C, Borie R, Dehoux M, et al. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. Eur Respir J 2008; 32: 426\u201336.","journal-title":"Eur Respir J"},{"key":"BFaps2010187_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0303-7207(96)03827-0","volume":"120","author":"TV Passaretti","year":"1996","unstructured":"Passaretti TV, Wilcox BD, Jeffrey JJ . Serotonin regulation of gene expression in uterine extracellular matrix: reciprocal effects on collagens and collagenase. Mol Cell Endocrinol 1996; 120: 125\u201332.","journal-title":"Mol Cell Endocrinol"},{"key":"BFaps2010187_CR30","doi-asserted-by":"publisher","first-page":"42830","DOI":"10.1074\/jbc.M205094200","volume":"277","author":"JK Shum","year":"2002","unstructured":"Shum JK, Melendez JA, Jeffrey JJ . Serotonin-induced MMP-13 production is mediated via phospholipase C, protein kinase C, and ERK1\/2 in rat uterine smooth muscle cells. J Biol Chem 2002; 277: 42830\u201340.","journal-title":"J Biol Chem"},{"key":"BFaps2010187_CR31","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/syn.20529","volume":"62","author":"M Benekareddy","year":"2008","unstructured":"Benekareddy M, Mehrotra P, Kulkarni VA, Ramakrishnan P, Dias BG, Vaidya VA . Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2\/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus. Synapse 2008; 62: 590\u2013600.","journal-title":"Synapse"},{"key":"BFaps2010187_CR32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.exer.2008.11.023","volume":"88","author":"KE Keller","year":"2009","unstructured":"Keller KE, Aga M, Bradley JM, Kelley MJ, Acott TS . Extracellular matrix turnover and outflow resistance. Exp Eye Res 2009; 88: 676\u201382.","journal-title":"Exp Eye Res"},{"key":"BFaps2010187_CR33","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.4049\/jimmunol.177.9.6422","volume":"177","author":"NM Kushnir-Sukhov","year":"2006","unstructured":"Kushnir-Sukhov NM, Gilfillan AM, Coleman JW, Brown JM, Bruening S, Toth M, et al. 5-hydroxytryptamine induces mast cell adhesion and migration. J Immunol 2006; 177: 6422\u201332.","journal-title":"J Immunol"},{"key":"BFaps2010187_CR34","doi-asserted-by":"publisher","first-page":"L272","DOI":"10.1152\/ajplung.00032.2010","volume":"299","author":"Z Mikulski","year":"2010","unstructured":"Mikulski Z, Zaslona Z, Cakarova L, Hartmann P, Wilhelm J, Tecott LH, et al. Serotonin activates murine alveolar macrophages through 5-HT2C receptors. Am J Physiol Lung Cell Mol Physiol 2010; 299: L272\u201380.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFaps2010187_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1365-2222.2007.02700.x","volume":"37","author":"C Lima","year":"2007","unstructured":"Lima C, Souza VM, Soares AL, Macedo MS, Tavares-de-Lima W, Vargaftig BB . Interference of methysergide, a specific 5-hydroxytryptamine receptor antagonist, with airway chronic allergic inflammation and remodeling in a murine model of asthma. Clin Exp Allergy 2007; 37: 723\u201334.","journal-title":"Clin Exp Allergy"},{"key":"BFaps2010187_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","volume":"19","author":"AM Manicone","year":"2008","unstructured":"Manicone AM, McGuire JK . Matrix metalloproteinases as modulators of inflammation. Cell Dev Biol 2008; 19: 34\u201341.","journal-title":"Cell Dev Biol"},{"key":"BFaps2010187_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","volume":"21","author":"M Kubera","year":"2001","unstructured":"Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M . Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma\/interleukin-10 production ratio. J Clin Psychopharmacol 2001; 21: 199\u2013206.","journal-title":"J Clin Psychopharmacol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2010187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2010187","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2010187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T22:25:46Z","timestamp":1712096746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2010187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,10]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["BFaps2010187"],"URL":"https:\/\/doi.org\/10.1038\/aps.2010.187","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,10]]}}}